Line 2,103: |
Line 2,103: |
| | | | | |
| | | | | |
| + | |}<br /> |
| + | |
| + | ==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content== |
| + | {| class="wikitable" |
| |- | | |- |
− | | || ||
| + | !'''Disease'''!!'''Page Type'''!!'''Author''' |
− | |
| + | !'''Date Assigned to Author''' |
− | |
| + | !'''Target Completion Date''' |
− | |
| + | !'''Author Content (Pending or Complete)''' |
− | | ||
| + | !'''Date Completed by Author'''!!'''Associate Editor''' |
− | |
| + | !'''Date of Last Editor Review''' |
− | |
| + | !'''Notes''' |
| |- | | |- |
− | | || || | + | |NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD |
| + | |2/20/2022 |
| | | | | |
| + | |PENDING |
| | | | | |
− | | | + | |Alanna Church |
− | | ||
| |
| | | | | |
| | | | | |
| |- | | |- |
− | | || || | + | |}<br /> |
− | |
| + | |
− | |
| + | ==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content== |
− | |
| + | {| class="wikitable" |
− | | ||
| + | |- |
− | |
| + | !'''Disease'''!!'''Page Type'''!!'''Author''' |
− | |
| + | !'''Date Assigned to Author''' |
| + | !'''Target Completion Date''' |
| + | !'''Author Content (Pending or Complete)''' |
| + | !'''Date Completed by Author'''!!'''Associate Editor''' |
| + | !'''Date of Last Editor Review''' |
| + | !'''Notes''' |
| |- | | |- |
− | | || || | + | |Astrocystoma, IDH-Mutant |
| + | |Disease |
| + | |Riley Lochner (trainee), Shashi Shetty (mentor) |
| + | |3/3/2022 |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |Laveniya Satgunaseelan (LS) |
| | | | | |
− | | || | + | |2021 template added |
− | |
| |
− | |
| |
| |- | | |- |
− | | || || | + | |Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor) |
| + | |3/3/2022 |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |Laveniya Satgunaseelan (LS) |
| | | | | |
− | | || | + | |2021 template added |
| + | |- |
| + | |Glioblastoma, IDH-Wildtype||Disease|| |
| | | | | |
| | | | | |
− | |-
| |
− | | || ||
| |
| | | | | |
| | | | | |
| | | | | |
− | | ||
| |
| | | | | |
| | | | | |
| |- | | |- |
− | | || || | + | |Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease|| |
| | | | | |
| | | | | |
| | | | | |
− | | ||
| |
| | | | | |
| | | | | |
− | |-
| |
− | | || ||
| |
| | | | | |
| + | | |
| + | |- |
| + | |Angiocentric Glioma||Disease|| |
| | | | | |
| | | | | |
− | | ||
| |
| | | | | |
| | | | | |
− | |-
| |
− | | || ||
| |
| | | | | |
| | | | | |
| | | | | |
− | | || | + | |- |
| + | |Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease|| |
| | | | | |
| | | | | |
− | |-
| |
− | | || ||
| |
| | | | | |
| | | | | |
| | | | | |
− | | ||
| |
| | | | | |
| | | | | |
| |- | | |- |
− | | || || | + | |Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease|| |
| + | | |
| + | | |
| | | | | |
| | | | | |
| | | | | |
− | | ||
| |
| | | | | |
| | | | | |
| |- | | |- |
− | | || || | + | |Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version) |
| | | | | |
| | | | | |
| + | |PENDING |
| | | | | |
− | | || | + | |LS |
| | | | | |
| + | |2021 template added |
| + | |- |
| + | |Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu |
| + | |2/21/2022 |
| | | | | |
− | |- | + | |PENDING |
− | | || ||
| |
| | | | | |
| + | |LS |
| | | | | |
| + | |2021 template added |
| + | |- |
| + | |Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova |
| + | |10/28/2022 |
| | | | | |
− | | || | + | |PENDING |
| | | | | |
| + | |LS |
| | | | | |
| + | |2021 template added |
| |- | | |- |
− | | || || | + | |Infant-Type Hemispheric Glioma||Disease|| |
| | | | | |
| | | | | |
| | | | | |
− | | ||
| |
| | | | | |
| | | | | |
− | |}<br /> | + | | |
− | | + | |2021 template added |
− | ==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content==
| |
− | {| class="wikitable"
| |
| |- | | |- |
− | !'''Disease'''!!'''Page Type'''!!'''Author'''
| + | |Pilocytic Astrocytoma||Disease||Jeremy Pulvers |
− | !'''Date Assigned to Author'''
| + | |9/13/2022<br /> |
− | !'''Target Completion Date'''
| + | | |
− | !'''Author Content (Pending or Complete)'''
| + | |PENDING |
− | !'''Date Completed by Author'''!!'''Associate Editor'''
| + | | |
− | !'''Date of Last Editor Review'''
| + | |LS |
− | !'''Notes'''
| + | | |
| + | |2021 template added |
| |- | | |- |
− | |NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD | + | |High-Grade Astrocytoma with Piloid Features||Disease|| |
− | |2/20/2022 | + | | |
| + | | |
| + | | |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |Alanna Church
| |
| | | | | |
| | | | | |
| |- | | |- |
− | |}<br /> | + | |Pleomorphic Xanthoastrocytoma||Disease|| |
− | | + | | |
− | ==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
| |
− | {| class="wikitable"
| |
− | |- | |
− | !'''Disease'''!!'''Page Type'''!!'''Author'''
| |
− | !'''Date Assigned to Author'''
| |
− | !'''Target Completion Date'''
| |
− | !'''Author Content (Pending or Complete)'''
| |
− | !'''Date Completed by Author'''!!'''Associate Editor'''
| |
− | !'''Date of Last Editor Review'''
| |
− | !'''Notes'''
| |
− | |- | |
− | |Astrocystoma, IDH-Mutant
| |
− | |Disease
| |
− | |Riley Lochner (trainee), Shashi Shetty (mentor) | |
− | |3/3/2022 | |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |Laveniya Satgunaseelan (LS)
| |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
| |
− | |3/3/2022
| |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |Laveniya Satgunaseelan (LS)
| |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |Glioblastoma, IDH-Wildtype||Disease|| | + | |Subependymal Giant Cell Astrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,279: |
Line 2,275: |
| | | | | |
| |- | | |- |
− | |Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease|| | + | |Chordoid Glioma||Disease|| |
| | | | | |
| | | | | |
Line 2,288: |
Line 2,284: |
| | | | | |
| |- | | |- |
− | |Angiocentric Glioma||Disease|| | + | |Astroblastoma, MN1-Altered||Disease|| |
| | | | | |
| | | | | |
Line 2,297: |
Line 2,293: |
| | | | | |
| |- | | |- |
− | |Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease|| | + | |Ganglioglioma||Disease||Leila Moayed-Aloei |
| + | |6/30/2022 |
| + | | |
| + | |COMPLETE |
| + | | |
| + | |LS |
| + | | |
| + | |2021 template added |
| + | |- |
| + | |Gangliocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,306: |
Line 2,311: |
| | | | | |
| |- | | |- |
− | |Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease|| | + | |Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,315: |
Line 2,320: |
| | | | | |
| |- | | |- |
− | |Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version) | + | |Dysembryoplastic Neuroepithelial Tumour||Disease|| |
| | | | | |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |LS
| |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
| |
− | |2/21/2022
| |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |LS
| |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova | + | |Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease|| |
− | |10/28/2022 | + | | |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |LS
| |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |Infant-Type Hemispheric Glioma||Disease||
| |
| | | | | |
| | | | | |
| + | | |
| + | |- |
| + | |Papillary Glioneuronal Tumour||Disease|| |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |Pilocytic Astrocytoma||Disease||Jeremy Pulvers
| |
− | |9/13/2022<br />
| |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |LS
| |
| | | | | |
− | |2021 template added
| |
| |- | | |- |
− | |High-Grade Astrocytoma with Piloid Features||Disease|| | + | |Rosette-Forming Glioneuronal Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,369: |
Line 2,356: |
| | | | | |
| |- | | |- |
− | |Pleomorphic Xanthoastrocytoma||Disease|| | + | |Myxoid Glioneuronal Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,378: |
Line 2,365: |
| | | | | |
| |- | | |- |
− | |Subependymal Giant Cell Astrocytoma||Disease|| | + | |Diffuse Lptomeningeal Glioneuronal Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,387: |
Line 2,374: |
| | | | | |
| |- | | |- |
− | |Chordoid Glioma||Disease|| | + | |Multinodular and Vacuolating Neuronal Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,396: |
Line 2,383: |
| | | | | |
| |- | | |- |
− | |Astroblastoma, MN1-Altered||Disease|| | + | |Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease|| |
| | | | | |
| | | | | |
Line 2,405: |
Line 2,392: |
| | | | | |
| |- | | |- |
− | |Ganglioglioma||Disease||Leila Moayed-Aloei | + | |Central Neurocytoma||Disease|| |
− | |6/30/2022
| |
− | |
| |
− | |COMPLETE
| |
− | |
| |
− | |LS
| |
− | |
| |
− | |2021 template added
| |
− | |-
| |
− | |Gangliocytoma||Disease||
| |
| | | | | |
| | | | | |
Line 2,423: |
Line 2,401: |
| | | | | |
| |- | | |- |
− | |Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease|| | + | |Extraventricular Neurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,432: |
Line 2,410: |
| | | | | |
| |- | | |- |
− | |Dysembryoplastic Neuroepithelial Tumour||Disease|| | + | |Cerebellar Liponeurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,441: |
Line 2,419: |
| | | | | |
| |- | | |- |
− | |Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease|| | + | |Supratentorial Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,450: |
Line 2,428: |
| | | | | |
| |- | | |- |
− | |Papillary Glioneuronal Tumour||Disease|| | + | |Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease|| |
| | | | | |
| | | | | |
Line 2,459: |
Line 2,437: |
| | | | | |
| |- | | |- |
− | |Rosette-Forming Glioneuronal Tumour||Disease|| | + | |Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease|| |
| | | | | |
| | | | | |
Line 2,468: |
Line 2,446: |
| | | | | |
| |- | | |- |
− | |Myxoid Glioneuronal Tumour||Disease|| | + | |Posterior Fossa Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,477: |
Line 2,455: |
| | | | | |
| |- | | |- |
− | |Diffuse Lptomeningeal Glioneuronal Tumour||Disease|| | + | |Posterior Fossa Group A (PFA) Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,486: |
Line 2,464: |
| | | | | |
| |- | | |- |
− | |Multinodular and Vacuolating Neuronal Tumour||Disease|| | + | |Posterior Fossa Group B (PFB) Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,495: |
Line 2,473: |
| | | | | |
| |- | | |- |
− | |Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease|| | + | |Spinal Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,504: |
Line 2,482: |
| | | | | |
| |- | | |- |
− | |Central Neurocytoma||Disease|| | + | |Spinal Ependymoma, MYCN-Amplified||Disease|| |
| | | | | |
| | | | | |
Line 2,513: |
Line 2,491: |
| | | | | |
| |- | | |- |
− | |Extraventricular Neurocytoma||Disease|| | + | |Myxopapillary Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,522: |
Line 2,500: |
| | | | | |
| |- | | |- |
− | |Cerebellar Liponeurocytoma||Disease|| | + | |Subependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,531: |
Line 2,509: |
| | | | | |
| |- | | |- |
− | |Supratentorial Ependymoma||Disease|| | + | |Choroid Plexus Papilloma||Disease|| |
| | | | | |
| | | | | |
Line 2,540: |
Line 2,518: |
| | | | | |
| |- | | |- |
− | |Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease|| | + | |Atypical Choroid Plexus Papilloma||Disease|| |
| | | | | |
| | | | | |
Line 2,549: |
Line 2,527: |
| | | | | |
| |- | | |- |
− | |Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease|| | + | |Choroid Plexus Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 2,558: |
Line 2,536: |
| | | | | |
| |- | | |- |
− | |Posterior Fossa Ependymoma||Disease|| | + | |Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City |
| + | |9/20/21 |
| + | | |
| + | |COMPLETE |
| + | | |
| + | |Holli Drendel (interim)/Laveniya Satgunaseelan (LS) |
| + | |9/22/2022 |
| + | |2021 template added |
| + | |- |
| + | |Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease|| |
| | | | | |
| | | | | |
Line 2,567: |
Line 2,554: |
| | | | | |
| |- | | |- |
− | |Posterior Fossa Group A (PFA) Ependymoma||Disease|| | + | |Medulloblastoma, SHH-Activated and TP53-Mutant||Disease|| |
| | | | | |
| | | | | |
Line 2,576: |
Line 2,563: |
| | | | | |
| |- | | |- |
− | |Posterior Fossa Group B (PFB) Ependymoma||Disease|| | + | |Medulloblastoma, Non-WNT/Non-SHH||Disease|| |
| | | | | |
| | | | | |
Line 2,585: |
Line 2,572: |
| | | | | |
| |- | | |- |
− | |Spinal Ependymoma||Disease|| | + | |Medulloblastoma, Histologically Defined||Disease|| |
| | | | | |
| | | | | |
Line 2,594: |
Line 2,581: |
| | | | | |
| |- | | |- |
− | |Spinal Ependymoma, MYCN-Amplified||Disease|| | + | |Atypical Teratoid/Rhabdoid Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,603: |
Line 2,590: |
| | | | | |
| |- | | |- |
− | |Myxopapillary Ependymoma||Disease|| | + | |Cribriform Neuroepithelial Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,612: |
Line 2,599: |
| | | | | |
| |- | | |- |
− | |Subependymoma||Disease|| | + | |Embryonal Tumour with Multilayered Rosettes||Disease|| |
| | | | | |
| | | | | |
Line 2,621: |
Line 2,608: |
| | | | | |
| |- | | |- |
− | |Choroid Plexus Papilloma||Disease|| | + | |CNS Neuroblastoma, FOXR2-Activated||Disease|| |
| | | | | |
| | | | | |
Line 2,630: |
Line 2,617: |
| | | | | |
| |- | | |- |
− | |Atypical Choroid Plexus Papilloma||Disease|| | + | |CNS Tumour with BCOR Internal Tandem Duplication||Disease|| |
| | | | | |
| | | | | |
Line 2,639: |
Line 2,626: |
| | | | | |
| |- | | |- |
− | |Choroid Plexus Carcinoma||Disease|| | + | |CNS Embryonal Tumour NEC/NOS||Disease|| |
| | | | | |
| | | | | |
Line 2,648: |
Line 2,635: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City | + | |Pineocytoma||Disease|| |
− | |9/20/21
| |
− | |
| |
− | |COMPLETE
| |
− | |
| |
− | |Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
| |
− | |9/22/2022
| |
− | |2021 template added
| |
− | |-
| |
− | |Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
| |
| | | | | |
| | | | | |
Line 2,666: |
Line 2,644: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, SHH-Activated and TP53-Mutant||Disease|| | + | |Pineal Parenchymal Tumour of Intermediate Differentiation||Disease|| |
| | | | | |
| | | | | |
Line 2,675: |
Line 2,653: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, Non-WNT/Non-SHH||Disease|| | + | |Pineoblastoma||Disease|| |
| | | | | |
| | | | | |
Line 2,684: |
Line 2,662: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, Histologically Defined||Disease|| | + | |Papillary Tumour of the Pineal Region||Disease|| |
| | | | | |
| | | | | |
Line 2,693: |
Line 2,671: |
| | | | | |
| |- | | |- |
− | |Atypical Teratoid/Rhabdoid Tumour||Disease|| | + | |Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease|| |
| | | | | |
| | | | | |
Line 2,702: |
Line 2,680: |
| | | | | |
| |- | | |- |
− | |Cribriform Neuroepithelial Tumour||Disease|| | + | |Schwannoma||Disease|| |
| | | | | |
| | | | | |
Line 2,711: |
Line 2,689: |
| | | | | |
| |- | | |- |
− | |Embryonal Tumour with Multilayered Rosettes||Disease|| | + | |Neurofibroma||Disease|| |
| | | | | |
| | | | | |
Line 2,720: |
Line 2,698: |
| | | | | |
| |- | | |- |
− | |CNS Neuroblastoma, FOXR2-Activated||Disease|| | + | |Perineurioma||Disease|| |
| | | | | |
| | | | | |
Line 2,729: |
Line 2,707: |
| | | | | |
| |- | | |- |
− | |CNS Tumour with BCOR Internal Tandem Duplication||Disease|| | + | |Hybrid Nerve Sheath Tumours||Disease|| |
| | | | | |
| | | | | |
Line 2,738: |
Line 2,716: |
| | | | | |
| |- | | |- |
− | |CNS Embryonal Tumour NEC/NOS||Disease|| | + | |Malignant Melanotic Nerve Sheath Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,747: |
Line 2,725: |
| | | | | |
| |- | | |- |
− | |Pineocytoma||Disease|| | + | |Malignant Peripheral Nerve Sheath Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,756: |
Line 2,734: |
| | | | | |
| |- | | |- |
− | |Pineal Parenchymal Tumour of Intermediate Differentiation||Disease|| | + | |Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease|| |
| | | | | |
| | | | | |
Line 2,765: |
Line 2,743: |
| | | | | |
| |- | | |- |
− | |Pineoblastoma||Disease|| | + | |Meningioma||Disease|| |
| | | | | |
| | | | | |
Line 2,774: |
Line 2,752: |
| | | | | |
| |- | | |- |
− | |Papillary Tumour of the Pineal Region||Disease|| | + | |Solitary Fibrous Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,783: |
Line 2,761: |
| | | | | |
| |- | | |- |
− | |Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease|| | + | |Haemangiomas and Vascular Malformations||Disease|| |
| | | | | |
| | | | | |
Line 2,792: |
Line 2,770: |
| | | | | |
| |- | | |- |
− | |Schwannoma||Disease|| | + | |Haemangioblastoma||Disease|| |
| | | | | |
| | | | | |
Line 2,801: |
Line 2,779: |
| | | | | |
| |- | | |- |
− | |Neurofibroma||Disease|| | + | |Rhabdomyosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 2,810: |
Line 2,788: |
| | | | | |
| |- | | |- |
− | |Perineurioma||Disease|| | + | |Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease|| |
| | | | | |
| | | | | |
Line 2,819: |
Line 2,797: |
| | | | | |
| |- | | |- |
− | |Hybrid Nerve Sheath Tumours||Disease|| | + | |CIC-Rearranged Sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 2,828: |
Line 2,806: |
| | | | | |
| |- | | |- |
− | |Malignant Melanotic Nerve Sheath Tumour||Disease|| | + | |Primary Intracranial Sarcoma, DICER1-Mutant||Disease|| |
| | | | | |
| | | | | |
Line 2,837: |
Line 2,815: |
| | | | | |
| |- | | |- |
− | |Malignant Peripheral Nerve Sheath Tumour||Disease|| | + | |Ewing Sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 2,846: |
Line 2,824: |
| | | | | |
| |- | | |- |
− | |Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease|| | + | |Mesenchymal Chondrosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 2,855: |
Line 2,833: |
| | | | | |
| |- | | |- |
− | |Meningioma||Disease|| | + | |Chondrosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 2,864: |
Line 2,842: |
| | | | | |
| |- | | |- |
− | |Solitary Fibrous Tumour||Disease|| | + | |Chordoma||Disease|| |
| | | | | |
| | | | | |
Line 2,873: |
Line 2,851: |
| | | | | |
| |- | | |- |
− | |Haemangiomas and Vascular Malformations||Disease|| | + | |Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease|| |
| | | | | |
| | | | | |
Line 2,882: |
Line 2,860: |
| | | | | |
| |- | | |- |
− | |Haemangioblastoma||Disease|| | + | |Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease|| |
| | | | | |
| | | | | |
Line 2,891: |
Line 2,869: |
| | | | | |
| |- | | |- |
− | |Rhabdomyosarcoma||Disease|| | + | |Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 2,900: |
Line 2,878: |
| | | | | |
| |- | | |- |
− | |Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease|| | + | |Immunodeficiency-Associated CNS Lymphomas||Disease|| |
| | | | | |
| | | | | |
Line 2,909: |
Line 2,887: |
| | | | | |
| |- | | |- |
− | |CIC-Rearranged Sarcoma||Disease|| | + | |Lymphomatoid Granulomatosis||Disease|| |
| | | | | |
| | | | | |
Line 2,918: |
Line 2,896: |
| | | | | |
| |- | | |- |
− | |Primary Intracranial Sarcoma, DICER1-Mutant||Disease|| | + | |Intravascular Large B-cell Lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 2,927: |
Line 2,905: |
| | | | | |
| |- | | |- |
− | |Ewing Sarcoma||Disease|| | + | |MALT Lymphoma of the Dura||Disease|| |
| | | | | |
| | | | | |
Line 2,936: |
Line 2,914: |
| | | | | |
| |- | | |- |
− | |Mesenchymal Chondrosarcoma||Disease|| | + | |Other Low-Grade B-cell Lymphomas of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 2,945: |
Line 2,923: |
| | | | | |
| |- | | |- |
− | |Chondrosarcoma||Disease|| | + | |Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease|| |
| | | | | |
| | | | | |
Line 2,954: |
Line 2,932: |
| | | | | |
| |- | | |- |
− | |Chordoma||Disease|| | + | |T-cell and NK/T-cell Lymphomas||Disease|| |
| | | | | |
| | | | | |
Line 2,963: |
Line 2,941: |
| | | | | |
| |- | | |- |
− | |Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease|| | + | |Erdheim-Chester Disease||Disease|| |
| | | | | |
| | | | | |
Line 2,972: |
Line 2,950: |
| | | | | |
| |- | | |- |
− | |Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease|| | + | |Rosai-Dorfman Disease||Disease|| |
| | | | | |
| | | | | |
Line 2,981: |
Line 2,959: |
| | | | | |
| |- | | |- |
− | |Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| | + | |Juvenile Xanthogranuloma||Disease|| |
| | | | | |
| | | | | |
Line 2,990: |
Line 2,968: |
| | | | | |
| |- | | |- |
− | |Immunodeficiency-Associated CNS Lymphomas||Disease|| | + | |Langerhans Cell Histiocytosis||Disease|| |
| | | | | |
| | | | | |
Line 2,999: |
Line 2,977: |
| | | | | |
| |- | | |- |
− | |Lymphomatoid Granulomatosis||Disease|| | + | |Histiocytic Sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,008: |
Line 2,986: |
| | | | | |
| |- | | |- |
− | |Intravascular Large B-cell Lymphoma||Disease|| | + | |Germ Cell Tumours of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,017: |
Line 2,995: |
| | | | | |
| |- | | |- |
− | |MALT Lymphoma of the Dura||Disease|| | + | |Adamantinomatous Craniopharyngioma||Disease|| |
| | | | | |
| | | | | |
Line 3,026: |
Line 3,004: |
| | | | | |
| |- | | |- |
− | |Other Low-Grade B-cell Lymphomas of the CNS||Disease|| | + | |Papillary Craniopharyngioma||Disease|| |
| | | | | |
| | | | | |
Line 3,035: |
Line 3,013: |
| | | | | |
| |- | | |- |
− | |Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease|| | + | |Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,044: |
Line 3,022: |
| | | | | |
| |- | | |- |
− | |T-cell and NK/T-cell Lymphomas||Disease|| | + | |Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,053: |
Line 3,031: |
| | | | | |
| |- | | |- |
− | |Erdheim-Chester Disease||Disease|| | + | |Pituitary Blastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,062: |
Line 3,040: |
| | | | | |
| |- | | |- |
− | |Rosai-Dorfman Disease||Disease|| | + | |Metastases to the Brain and Spinal Cord Parenchyma||Disease|| |
| | | | | |
| | | | | |
Line 3,071: |
Line 3,049: |
| | | | | |
| |- | | |- |
− | |Juvenile Xanthogranuloma||Disease|| | + | |Metastases to the Meninges||Disease|| |
| | | | | |
| | | | | |
Line 3,080: |
Line 3,058: |
| | | | | |
| |- | | |- |
− | |Langerhans Cell Histiocytosis||Disease|| | + | |Neurofibromatosis Type 1||Disease|| |
| | | | | |
| | | | | |
Line 3,089: |
Line 3,067: |
| | | | | |
| |- | | |- |
− | |Histiocytic Sarcoma||Disease|| | + | |Neurofibromatosis Type 2||Disease|| |
| | | | | |
| | | | | |
Line 3,098: |
Line 3,076: |
| | | | | |
| |- | | |- |
− | |Germ Cell Tumours of the CNS||Disease|| | + | |Schwannomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,107: |
Line 3,085: |
| | | | | |
| |- | | |- |
− | |Adamantinomatous Craniopharyngioma||Disease|| | + | |Von Hippel-Lindau Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,116: |
Line 3,094: |
| | | | | |
| |- | | |- |
− | |Papillary Craniopharyngioma||Disease|| | + | |Tuberous Sclerosis||Disease|| |
| | | | | |
| | | | | |
Line 3,125: |
Line 3,103: |
| | | | | |
| |- | | |- |
− | |Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease|| | + | |Li-Fraumeni Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,134: |
Line 3,112: |
| | | | | |
| |- | | |- |
− | |Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease|| | + | |Cowden Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,143: |
Line 3,121: |
| | | | | |
| |- | | |- |
− | |Pituitary Blastoma||Disease|| | + | |Constitutional Mismatch Repair Deficiency Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,152: |
Line 3,130: |
| | | | | |
| |- | | |- |
− | |Metastases to the Brain and Spinal Cord Parenchyma||Disease|| | + | |Familial Adenomatous Polyposis 1||Disease|| |
| | | | | |
| | | | | |
Line 3,161: |
Line 3,139: |
| | | | | |
| |- | | |- |
− | |Metastases to the Meninges||Disease|| | + | |Naevoid Basal Cell Carcinoma Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,170: |
Line 3,148: |
| | | | | |
| |- | | |- |
− | |Neurofibromatosis Type 1||Disease|| | + | |Rhabdoid Tumour Predisposition Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,179: |
Line 3,157: |
| | | | | |
| |- | | |- |
− | |Neurofibromatosis Type 2||Disease|| | + | |Carney Complex||Disease|| |
| | | | | |
| | | | | |
Line 3,188: |
Line 3,166: |
| | | | | |
| |- | | |- |
− | |Schwannomatosis||Disease|| | + | |DICER1 Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,197: |
Line 3,175: |
| | | | | |
| |- | | |- |
− | |Von Hippel-Lindau Syndrome||Disease|| | + | |Familial Paraganglioma Syndromes||Disease|| |
| | | | | |
| | | | | |
Line 3,206: |
Line 3,184: |
| | | | | |
| |- | | |- |
− | |Tuberous Sclerosis||Disease|| | + | |Melanoma-Astrocytoma Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,215: |
Line 3,193: |
| | | | | |
| |- | | |- |
− | |Li-Fraumeni Syndrome||Disease|| | + | |Familial Retinoblastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,224: |
Line 3,202: |
| | | | | |
| |- | | |- |
− | |Cowden Syndrome||Disease|| | + | |BAP1 Tumour Predisposition Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,233: |
Line 3,211: |
| | | | | |
| |- | | |- |
− | |Constitutional Mismatch Repair Deficiency Syndrome||Disease|| | + | |Fanconi Anaemia||Disease|| |
| | | | | |
| | | | | |
Line 3,242: |
Line 3,220: |
| | | | | |
| |- | | |- |
− | |Familial Adenomatous Polyposis 1||Disease|| | + | |ELP1-Medulloblastoma Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,251: |
Line 3,229: |
| | | | | |
| |- | | |- |
− | |Naevoid Basal Cell Carcinoma Syndrome||Disease|| | + | |}<br /> |
− | | | + | ==WHO Classification of Tumours of Breast Tumours (5th Edition) Content== |
− | | | + | {| class="wikitable" |
− | | | + | |- |
− | | | + | !'''Disease'''!!'''Page Type'''!!'''Author''' |
| + | !'''Date Assigned to Author''' |
| + | !'''Target Completion Date''' |
| + | !'''Author Content (Pending or Complete)''' |
| + | !'''Date Completed by Author'''!!'''Associate Editor''' |
| + | !'''Date of Last Editor Review''' |
| + | !'''Notes''' |
| + | |- |
| + | |Adenoid Cystic Carcinoma |
| + | |Disease||Katherine Geiersbach |
| + | |10/12/02022 |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |Hui Chen |
| | | | | |
| + | |2021 template added |
| |- | | |- |
− | |Rhabdoid Tumour Predisposition Syndrome||Disease|| | + | |Secretory Carcinoma |
| + | |Disease |
| + | |Hui Chen |
| + | |10/12/2022 |
| + | | |
| + | |PENDING |
| + | | |
| + | |Katherine Geiersbach |
| + | | |
| + | |2021 template added |
| + | |- |
| + | |}<br /> |
| + | |
| + | ==WHO Classification of Tumours of Breast Tumours (5th Edition) Content== |
| + | {| class="wikitable" |
| + | |- |
| + | !'''Disease'''!!'''Page Type'''!!'''Author''' |
| + | !'''Date Assigned to Author''' |
| + | !'''Target Completion Date''' |
| + | !'''Author Content (Pending or Complete)''' |
| + | !'''Date Completed by Author'''!!'''Associate Editor''' |
| + | !'''Date of Last Editor Review''' |
| + | !'''Notes''' |
| + | |- |Usual ductal hyperplasia||Disease|| |
| | | | | |
| | | | | |
Line 3,269: |
Line 3,283: |
| | | | | |
| |- | | |- |
− | |Carney Complex||Disease|| | + | |Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease|| |
| | | | | |
| | | | | |
Line 3,278: |
Line 3,292: |
| | | | | |
| |- | | |- |
− | |DICER1 Syndrome||Disease|| | + | |Atypical Ductal Hyperplasia||Disease|| |
| | | | | |
| | | | | |
Line 3,287: |
Line 3,301: |
| | | | | |
| |- | | |- |
− | |Familial Paraganglioma Syndromes||Disease|| | + | |Sclerosing Adenosis||Disease|| |
| | | | | |
| | | | | |
Line 3,296: |
Line 3,310: |
| | | | | |
| |- | | |- |
− | |Melanoma-Astrocytoma Syndrome||Disease|| | + | |Apocrine Adenosis and Adenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,305: |
Line 3,319: |
| | | | | |
| |- | | |- |
− | |Familial Retinoblastoma||Disease|| | + | |Microglandular Adenosis||Disease|| |
| | | | | |
| | | | | |
Line 3,314: |
Line 3,328: |
| | | | | |
| |- | | |- |
− | |BAP1 Tumour Predisposition Syndrome||Disease|| | + | |Radial Scar/Complex Sclerosing Lesion||Disease|| |
| | | | | |
| | | | | |
Line 3,323: |
Line 3,337: |
| | | | | |
| |- | | |- |
− | |Fanconi Anaemia||Disease|| | + | |Tubular Adenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,332: |
Line 3,346: |
| | | | | |
| |- | | |- |
− | |ELP1-Medulloblastoma Syndrome||Disease|| | + | |Lactating Adenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,341: |
Line 3,355: |
| | | | | |
| |- | | |- |
− | |}<br /> | + | |Ductal Adenoma||Disease|| |
− | ==WHO Classification of Tumours of Breast Tumours (5th Edition) Content==
| + | | |
− | {| class="wikitable"
| |
− | |-
| |
− | !'''Disease'''!!'''Page Type'''!!'''Author'''
| |
− | !'''Date Assigned to Author'''
| |
− | !'''Target Completion Date'''
| |
− | !'''Author Content (Pending or Complete)'''
| |
− | !'''Date Completed by Author'''!!'''Associate Editor'''
| |
− | !'''Date of Last Editor Review'''
| |
− | !'''Notes'''
| |
− | |-
| |
− | |Adenoid Cystic Carcinoma
| |
− | |Disease||Katherine Geiersbach | |
− | |10/12/02022 | |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |Hui Chen
| |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |Secretory Carcinoma
| |
− | |Disease
| |
− | |Hui Chen
| |
− | |10/12/2022
| |
| | | | | |
− | |PENDING
| |
| | | | | |
− | |Katherine Geiersbach
| |
| | | | | |
− | |2021 template added
| |
− | |-
| |
− | |}<br />
| |
− |
| |
− | ==WHO Breast tumours (5th ed.) Content==
| |
− | {| class="wikitable"
| |
| |- | | |- |
− | !'''Disease'''!!'''Page Type'''!!'''Author'''
| + | |Pleomorphic Adenoma||Disease|| |
− | !'''Date Assigned to Author'''
| |
− | !'''Target Completion Date'''
| |
− | !'''Author Content (Pending or Complete)'''
| |
− | !'''Date Completed by Author'''!!'''Associate Editor'''
| |
− | !'''Date of Last Editor Review'''
| |
− | !'''Notes'''
| |
− | |- |Usual ductal hyperplasia||Disease|| | |
| | | | | |
| | | | | |
Line 3,395: |
Line 3,373: |
| | | | | |
| |- | | |- |
− | |Columnar cell lesions, including flat epithelial atypia||Disease|| | + | |Adenomyoepithelioma||Disease|| |
| | | | | |
| | | | | |
Line 3,404: |
Line 3,382: |
| | | | | |
| |- | | |- |
− | |Atypical ductal hyperplasia||Disease|| | + | |Malignant Adenomyoepithelioma||Disease|| |
| | | | | |
| | | | | |
Line 3,413: |
Line 3,391: |
| | | | | |
| |- | | |- |
− | |Sclerosing adenosis||Disease|| | + | |Intraductal Papilloma||Disease|| |
| | | | | |
| | | | | |
Line 3,422: |
Line 3,400: |
| | | | | |
| |- | | |- |
− | |Apocrine adenosis and adenoma||Disease|| | + | |Papillary Ductal Carcinoma In Situ||Disease|| |
| | | | | |
| | | | | |
Line 3,431: |
Line 3,409: |
| | | | | |
| |- | | |- |
− | |Microglandular adenosis||Disease|| | + | |Encapsulated Papillary Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,440: |
Line 3,418: |
| | | | | |
| |- | | |- |
− | |Radial scar / complex sclerosing lesion||Disease|| | + | |Solid Papillary Carcinoma (In Situ and Invasive)||Disease|| |
| | | | | |
| | | | | |
Line 3,449: |
Line 3,427: |
| | | | | |
| |- | | |- |
− | |Tubular adenoma||Disease|| | + | |Invasive Papillary Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,458: |
Line 3,436: |
| | | | | |
| |- | | |- |
− | |Lactating adenoma||Disease|| | + | |Atypical Lobular Hyperplasia||Disease|| |
| | | | | |
| | | | | |
Line 3,467: |
Line 3,445: |
| | | | | |
| |- | | |- |
− | |Ductal adenoma||Disease|| | + | |Lobular Carcinoma In Situ||Disease|| |
| | | | | |
| | | | | |
Line 3,476: |
Line 3,454: |
| | | | | |
| |- | | |- |
− | |Pleomorphic adenoma||Disease|| | + | |Ductal Carcinoma In Situ||Disease|| |
| | | | | |
| | | | | |
Line 3,485: |
Line 3,463: |
| | | | | |
| |- | | |- |
− | |Adenomyoepithelioma||Disease|| | + | |Invasive breast carcinoma: General overview||Disease||???? |
| | | | | |
| | | | | |
Line 3,494: |
Line 3,472: |
| | | | | |
| |- | | |- |
− | |Malignant adenomyoepithelioma||Disease|| | + | |Invasive Breast Carcinoma of No Special Type||Disease|| |
| | | | | |
| | | | | |
Line 3,503: |
Line 3,481: |
| | | | | |
| |- | | |- |
− | |Intraductal papilloma||Disease|| | + | |Microinvasive Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,512: |
Line 3,490: |
| | | | | |
| |- | | |- |
− | |Papillary ductal carcinoma in situ||Disease|| | + | |Invasive lobular Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,521: |
Line 3,499: |
| | | | | |
| |- | | |- |
− | |Encapsulated papillary carcinoma||Disease|| | + | |Tubular Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,530: |
Line 3,508: |
| | | | | |
| |- | | |- |
− | |Solid papillary carcinoma (in situ and invasive)||Disease|| | + | |Cribriform Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,539: |
Line 3,517: |
| | | | | |
| |- | | |- |
− | |Invasive papillary carcinoma||Disease|| | + | |Mucinous Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,548: |
Line 3,526: |
| | | | | |
| |- | | |- |
− | |Atypical lobular hyperplasia||Disease|| | + | |Mucinous Cystadenocarcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,557: |
Line 3,535: |
| | | | | |
| |- | | |- |
− | |Lobular carcinoma in situ||Disease|| | + | |Invasive Micropapillary Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,566: |
Line 3,544: |
| | | | | |
| |- | | |- |
− | |Ductal carcinoma in situ||Disease|| | + | |Carcinoma with Apocrine Differentiation||Disease|| |
| | | | | |
| | | | | |
Line 3,575: |
Line 3,553: |
| | | | | |
| |- | | |- |
− | |Invasive breast carcinoma: General overview||Disease|| | + | |Metaplastic Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,584: |
Line 3,562: |
| | | | | |
| |- | | |- |
− | |Invasive breast carcinoma of no special type||Disease|| | + | |Acinic Cell Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,593: |
Line 3,571: |
| | | | | |
| |- | | |- |
− | |Microinvasive carcinoma||Disease|| | + | |Adenoid Cystic Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,602: |
Line 3,580: |
| | | | | |
| |- | | |- |
− | |Invasive lobular carcinoma||Disease|| | + | |Secretory Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,611: |
Line 3,589: |
| | | | | |
| |- | | |- |
− | |Tubular carcinoma||Disease|| | + | |Mucoepidermoid Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,620: |
Line 3,598: |
| | | | | |
| |- | | |- |
− | |Cribriform carcinoma||Disease|| | + | |Polymorphous Adenocarcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,629: |
Line 3,607: |
| | | | | |
| |- | | |- |
− | |Mucinous carcinoma||Disease|| | + | |Tall Cell Carcinoma with Reversed Polarity||Disease|| |
| | | | | |
| | | | | |
Line 3,638: |
Line 3,616: |
| | | | | |
| |- | | |- |
− | |Mucinous cystadenocarcinoma||Disease|| | + | |Neuroendocrine Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,647: |
Line 3,625: |
| | | | | |
| |- | | |- |
− | |Invasive micropapillary carcinoma||Disease|| | + | |Neuroendocrine Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,656: |
Line 3,634: |
| | | | | |
| |- | | |- |
− | |Carcinoma with apocrine differentiation||Disease|| | + | |Hamartoma||Disease|| |
| | | | | |
| | | | | |
Line 3,665: |
Line 3,643: |
| | | | | |
| |- | | |- |
− | |Metaplastic carcinoma||Disease|| | + | |Fibroadenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,674: |
Line 3,652: |
| | | | | |
| |- | | |- |
− | |Acinic cell carcinoma||Disease|| | + | |Phyllodes Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,683: |
Line 3,661: |
| | | | | |
| |- | | |- |
− | |Adenoid cystic carcinoma||Disease|| | + | |Syringomatous Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,692: |
Line 3,670: |
| | | | | |
| |- | | |- |
− | |Secretory carcinoma||Disease|| | + | |Nipple Adenoma||Disease|| |
| | | | | |
| | | | | |
Line 3,701: |
Line 3,679: |
| | | | | |
| |- | | |- |
− | |Mucoepidermoid carcinoma||Disease|| | + | |Paget disease of the Breast||Disease|| |
| | | | | |
| | | | | |
Line 3,710: |
Line 3,688: |
| | | | | |
| |- | | |- |
− | |Polymorphous adenocarcinoma||Disease|| | + | |Haemangioma||Disease|| |
| | | | | |
| | | | | |
Line 3,719: |
Line 3,697: |
| | | | | |
| |- | | |- |
− | |Tall cell carcinoma with reversed polarity||Disease|| | + | |Angiomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,728: |
Line 3,706: |
| | | | | |
| |- | | |- |
− | |Neuroendocrine tumour||Disease|| | + | |Atypical Vascular Lesions||Disease|| |
| | | | | |
| | | | | |
Line 3,737: |
Line 3,715: |
| | | | | |
| |- | | |- |
− | |Neuroendocrine carcinoma||Disease|| | + | |Postradiation Angiosarcoma of the Breast||Disease|| |
| | | | | |
| | | | | |
Line 3,746: |
Line 3,724: |
| | | | | |
| |- | | |- |
− | |Hamartoma||Disease|| | + | |Primary Angiosarcoma of the Breast||Disease|| |
| | | | | |
| | | | | |
Line 3,755: |
Line 3,733: |
| | | | | |
| |- | | |- |
− | |Fibroadenoma||Disease|| | + | |Nodular Fasciitis||Disease|| |
| | | | | |
| | | | | |
Line 3,764: |
Line 3,742: |
| | | | | |
| |- | | |- |
− | |Phyllodes tumour||Disease|| | + | |Myofibroblastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,773: |
Line 3,751: |
| | | | | |
| |- | | |- |
− | |Syringomatous tumour||Disease|| | + | |Desmoid Fibromatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,782: |
Line 3,760: |
| | | | | |
| |- | | |- |
− | |Nipple adenoma||Disease|| | + | |Inflammatory Myofibroblastic Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,791: |
Line 3,769: |
| | | | | |
| |- | | |- |
− | |Paget disease of the breast||Disease|| | + | |Schwannoma||Disease|| |
| | | | | |
| | | | | |
Line 3,800: |
Line 3,778: |
| | | | | |
| |- | | |- |
− | |Haemangioma||Disease|| | + | |Neurofibroma||Disease|| |
| | | | | |
| | | | | |
Line 3,809: |
Line 3,787: |
| | | | | |
| |- | | |- |
− | |Angiomatosis||Disease|| | + | |Granular Cell Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,818: |
Line 3,796: |
| | | | | |
| |- | | |- |
− | |Atypical vascular lesions||Disease|| | + | |Leiomyoma||Disease|| |
| | | | | |
| | | | | |
Line 3,827: |
Line 3,805: |
| | | | | |
| |- | | |- |
− | |Postradiation angiosarcoma of the breast||Disease|| | + | |Leiomyosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,836: |
Line 3,814: |
| | | | | |
| |- | | |- |
− | |Primary angiosarcoma of the breast||Disease|| | + | |Lipoma||Disease|| |
| | | | | |
| | | | | |
Line 3,845: |
Line 3,823: |
| | | | | |
| |- | | |- |
− | |Nodular fasciitis||Disease|| | + | |Angiolipoma||Disease|| |
| | | | | |
| | | | | |
Line 3,854: |
Line 3,832: |
| | | | | |
| |- | | |- |
− | |Myofibroblastoma||Disease|| | + | |Liposarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,863: |
Line 3,841: |
| | | | | |
| |- | | |- |
− | |Desmoid fibromatosis||Disease|| | + | |Pseudoangiomatous Stromal Hyperplasia||Disease|| |
| | | | | |
| | | | | |
Line 3,872: |
Line 3,850: |
| | | | | |
| |- | | |- |
− | |Inflammatory myofibroblastic tumour||Disease|| | + | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease|| |
| | | | | |
| | | | | |
Line 3,881: |
Line 3,859: |
| | | | | |
| |- | | |- |
− | |Schwannoma||Disease|| | + | |Follicular Lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 3,890: |
Line 3,868: |
| | | | | |
| |- | | |- |
− | |Neurofibroma||Disease|| | + | |Diffuse Large B-cell Lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 3,899: |
Line 3,877: |
| | | | | |
| |- | | |- |
− | |Granular cell tumour||Disease|| | + | |Burkitt Lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 3,908: |
Line 3,886: |
| | | | | |
| |- | | |- |
− | |Leiomyoma||Disease|| | + | |Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 3,917: |
Line 3,895: |
| | | | | |
| |- | | |- |
− | |Leiomyosarcoma||Disease|| | + | |Gynaecomastia||Disease|| |
| | | | | |
| | | | | |
Line 3,926: |
Line 3,904: |
| | | | | |
| |- | | |- |
− | |Lipoma||Disease|| | + | |Carcinoma In Situ||Disease|| |
| | | | | |
| | | | | |
Line 3,935: |
Line 3,913: |
| | | | | |
| |- | | |- |
− | |Angiolipoma||Disease|| | + | |Invasive Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 3,944: |
Line 3,922: |
| | | | | |
| |- | | |- |
− | |Liposarcoma||Disease|| | + | |Metastases to the Breast||Disease|| |
| | | | | |
| | | | | |
Line 3,953: |
Line 3,931: |
| | | | | |
| |- | | |- |
− | |Pseudoangiomatous stromal hyperplasia||Disease|| | + | |BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,962: |
Line 3,940: |
| | | | | |
| |- | | |- |
− | |Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)||Disease|| | + | |Cowden Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,971: |
Line 3,949: |
| | | | | |
| |- | | |- |
− | |Follicular lymphoma||Disease|| | + | |Ataxia-Telangiectasia||Disease|| |
| | | | | |
| | | | | |
Line 3,980: |
Line 3,958: |
| | | | | |
| |- | | |- |
− | |Diffuse large B-cell lymphoma||Disease|| | + | |Li-Fraumeni Syndrome, TP53-Associated||Disease|| |
| | | | | |
| | | | | |
Line 3,989: |
Line 3,967: |
| | | | | |
| |- | | |- |
− | |Burkitt lymphoma||Disease|| | + | |Li-Fraumeni Syndrome, CHEK2-Associated||Disease|| |
| | | | | |
| | | | | |
Line 3,998: |
Line 3,976: |
| | | | | |
| |- | | |- |
− | |Breast implant-associated anaplastic large cell lymphoma||Disease|| | + | |CDH1-Associated Breast Cancer||Disease|| |
| | | | | |
| | | | | |
Line 4,007: |
Line 3,985: |
| | | | | |
| |- | | |- |
− | |Gynaecomastia||Disease|| | + | |PALB2-Associated Cancers||Disease|| |
| | | | | |
| | | | | |
Line 4,016: |
Line 3,994: |
| | | | | |
| |- | | |- |
− | |Carcinoma in situ||Disease|| | + | |Peutz-Jeghers Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 4,025: |
Line 4,003: |
| | | | | |
| |- | | |- |
− | |Invasive carcinoma||Disease||
| + | |Neurofibromatosis Type 1||Disease|| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Metastases to the breast||Disease||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |BRCA1/2-associated hereditary breast and ovarian cancer syndrome||Disease||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Cowden syndrome||Disease||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Ataxia-telangiectasia||Disease||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Li-Fraumeni syndrome, TP53-associated||Disease||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Li-Fraumeni syndrome, CHEK2-associated||Disease||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |CDH1-associated breast cancer||Disease||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |PALB2-associated cancers||Disease||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Peutz-Jeghers syndrome||Disease||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |Neurofibromatosis type 1||Disease|| | |
| | | | | |
| | | | | |